Status:

COMPLETED

Early Left Atrial Septostomy Versus Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation

Lead Sponsor:

Chonnam National University Hospital

Conditions:

Cardiogenic Shock

Eligibility:

All Genders

19+ years

Phase:

NA

Brief Summary

The use of venoarterial-extracorporeal membrane oxygenation(VA-ECMO) was associated with lower in-hospital mortality in patients with cardiogenic shock. However, VA-ECMO has a deleterious effect for h...

Detailed Description

Study Objectives: To determine the effect of early left atrial septostomy versus conventional approach(left atrial septostomy only in cases of significant changes due to left ventricular end-diastoli...

Eligibility Criteria

Inclusion

  • 1\) Age more than 18 years old 2) Cardiogenic shock\* 3) Successful VA-ECMO implantation
  • The definition of cardiogenic shock All these criteria should be met
  • Systolic blood pressure \< 90 mmHg for 30 minutes, or needing inotrope or vasopressor to maintain systolic blood pressure \> or = 90 mmHg
  • Pulmonary congestion on chest X-ray or increased left ventricular filling pressure by cardiac catheterization
  • At least one criteria of organ dysfunction
  • \- mental obtundation, clammy skin, oliguria, renal dysfunction, increased level of blood lactate

Exclusion

  • <!-- -->
  • VA-ECMO after open heart surgery
  • VA-ECMO for the treatment of non-cardiac shock
  • Severe bleeding\*
  • Terminal malignancy
  • Irreversible brain damage
  • Pregnancy or lactation
  • The definition of severe bleeding Hemoglobin decrease after VA-ECMO or cannulation site bleeding is not a exclusion criteria
  • Hypovolemic shock due to definite bleeding cause
  • Identifiable bleeding causes: gastrointestinal bleeding, hemothorax, traumatic bleeding, central nervous system hemorrhage, pulmonary hemorrhage

Key Trial Info

Start Date :

March 4 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 31 2023

Estimated Enrollment :

116 Patients enrolled

Trial Details

Trial ID

NCT04775472

Start Date

March 4 2021

End Date

October 31 2023

Last Update

January 12 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Chonnam National University Hospital

Gwangju, South Korea